No insider bought or sold Checkmate Pharmaceuticals, Inc. in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

Follow CMPI

CMPI over the last year

Prices for CMPI aren't in yet.

CMPI after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

13 insider filings since 2020, newest first

CMPISell

Venbio Global Strategic Fund II L.P. · 10% owner

$1.4M−6.0%May 17

CMPISell

Venbio Global Strategic Fund II L.P. · 10% owner

$1.7M−7.0%May 12

CMPISell

Venbio Global Strategic Fund II L.P. · 10% owner

$899K−3.0%May 9

CMPISell

Venbio Global Strategic Fund II L.P. · 10% owner

$2.8M−10.0%May 4

CMPISell

Venbio Global Strategic Fund II L.P. · 10% owner

$2.0M−6.0%Apr 29

CMPISell

Venbio Global Strategic Fund II L.P. · 10% owner

$1.3M−4.0%Apr 26

CMPISell

Venbio Global Strategic Fund II L.P. · 10% owner

$5.7M−15.0%Apr 21

CMPIBuy

Arthur M Krieg · Chief Scientific Officer

$166K+1.0%Mar 29

CMPIBuy

Arthur M Krieg · Chief Scientific Officer

$75K+1.0%Dec 23

CMPIBuy

Arthur M Krieg · Chief Scientific Officer

$71K+1.0%Dec 17

CMPIBuy

Novo Holdings A/s · 10% owner

$7.5M+30.0%Aug 13

CMPIBuy

Michael Powell · Director and 10% owner

$2.0M+4.0%Aug 12

CMPIBuy

Venbio Global Strategic Fund II L.P. · 10% owner

$3.0M+6.0%Aug 12

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.